Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer
Clinical trial NCT00046787 · COMPLETED
Trial details
- NCT number
- NCT00046787
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.